Women with pregnancies had lower adherence to 1 % tenofovir gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial in PloS One, Vol. 8, n° 3 (mars 2013) 
 | ||||||||||||||||||||||||||||
|
[article]
|
